March 15, 2026

🛋️ MRKTcap

Sponsored by

🥳 Happy Sunday!

​
In this newsletter we're diving into:

⛽ why the oil fix did not fix a thing

🤖 why one earnings report made Wall Street ease up on the AI fear

💉 why one courtroom mess turned into a stock rocket

​
Plus, the EV fight in China took another turn.

​
Make yourself comfy 🛋️ and let's get into it...

Market Crowd​
​How the market did this week.

*As of market close on Friday, March 13th.

Pre-Market Play​
​A market beat to start your week.
​

Dey Know

Shawty Lo

0:44 3:45

🛢️ 400 million barrels dropped...

And the market filed it under 'so what'

The IEA (International Energy Agency, a group of 30+ wealthy nations with emergency oil stockpiles on deck) made the biggest reserve release ℹ️ in its history.

​
400 million barrels of oil.

​
The US added another 172 million from its Strategic Petroleum Reserve, the country’s emergency oil stash.

​
Oil prices went up anyway.

​
WTI (US crude) climbed 7.5% to $93.8 a barrel Thursday.

​
Brent crude, the global benchmark, rose 7.74% to $99.1.

​
Why?

​
The Strait of Hormuz is the narrow waterway between Iran and Oman moving about 20% of the world’s oil every single day. The US-Iran war started February 28 and brought shipping through it to a near standstill.

​
The reserve release won’t close the gap.

​
Analysts say the Strait moves close to 20 million barrels a day. Even the biggest release in IEA history only covers about 20 days of what’s been lost.

​
None of it reaches buyers quickly either. Analysts estimate it takes 60 to 90 days for the oil to meaningfully hit the market.

​
“Prices right now are still in panic mode,” said Pavel Molchanov, senior investment strategist at Raymond James.

​
Energy stocks like the Energy Select Sector SPDR Fund (XLE) have been moving with every headline out of the Middle East.

​
🥡 The Takeaway: The government threw its biggest punches and oil shrugged. Watch for news about the Strait of Hormuz reopening. It’s the one event with the power to pull prices back down.

💰 Oracle answered the call...

And Wall Street let out a deep breath.

​
Oracle (ORCL) stock jumped 12% after Q3 earnings gave Wall Street exactly what it needed.

​
Here’s what’s been going down…

​
Back in February, Oracle announced a plan to raise up to $50 billion in 2026 through a mix of debt and equity to fund their AI data center buildout. Investors got nervous.

​
Then OpenAI pulled out of an expansion in Abilene, Texas, and the worry got louder.

​
But Tuesday’s earnings call flipped the script.

​
CEO Clayton Magouyrk said no more debt raises in 2026 beyond what was already announced. “Our operating model is optimized to ensure profitability,” he told analysts.

​
Then came the receipts.

​
Oracle signed more than $29 billion in new contracts.

​
They delivered 90% of their 400-megawatt data centers on or ahead of schedule.

​
And their remaining performance obligations, which are future contracts already locked in, more than quadrupled to $553 billion.

​
Not a company in trouble.

​
They also named Cerebras chips alongside Nvidia (NVDA) and AMD (AMD) on the call, a signal the AI chip race has more players than Wall Street expected.

​
🥡 The Takeaway: Oracle walked in with receipts and shut down every question about their AI debt plan. Watch ORCL for follow-through. Keep NVDA on your radar. Nvidia’s GTC conference is next week and a new chip announcement is the next catalyst to watch.

🔮 Wish you had a crystal ball to predict the market? ​ Yeah, don’t we all. But let’s be real. There's no such thing. So, while you're over there reading tea leaves, we’ll be over here using actual data. Meet Swingset, the swing trading app that digs through 15+ years of stock prices, uncovering trends that repeat over 70% of the time. It’s like that “friend” who always has insider info. Except legal. Pick a trend, check your charts, and trade smarter, not harder. Our members are cashing in, like Robert with his $1,206 win. Swingset: because while crystal balls don’t exist, but trends do. Give it a spin with a free trial. ​ Want to advertise with us? ​Get in touch​

​

💊 Squashed the beef...

Hims & Hers (HIMS) climbed 43% Monday after Novo Nordisk (NVO) dropped its patent infringement lawsuit.

​
In exchange?

​
Hims agreed to sell branded Ozempic and Wegovy through its platform at the same price as other telehealth providers, and stop advertising compounded GLP-1 drugs altogether.

​
Here’s what’s been going down…

​
Back in February, Novo sued Hims after the telehealth company announced a $49 copycat version of the Wegovy pill, roughly $100 less than Novo’s own price on its direct-to-consumer platform. The FDA stepped in, called it illegal, and referred Hims to the Department of Justice.

​
Hims pulled the pill fast.

​
This isn’t their first rodeo together, either. Novo and Hims tried a partnership last year for discounted weight loss injections. Novo ended it two months in, saying Hims used “deceptive” marketing that put patients at risk.

​
“It’s a very different situation than the last time,” Novo CEO Mike Doustdar told CNBC.

​
NVO ticked up 1.5% on the news but HIMS was the winner here.

​
And Eli Lilly (LLY)? Still cooking.

​
An oral weight loss pill called orforglipron is expected to hit the market in Q2, pending FDA approval, and our algorithm shows an upward trend lining up this week.

​
🥡 The Takeaway: HIMS cleared its biggest legal cloud and now sells branded Novo drugs through its platform. Watch if the stock holds its 43% gain or gives some back as traders decide if this new business model is worth the premium.

💫 TMYK
​A quick pop quiz to help you learn about the market. The more you know!​
​

When bond ______ rise, stocks often struggle because “safe” returns start looking better.

a.) splits

b.) floats

c.) yields

​
Scroll down for the answer!

Gimme some mo'
​More news from 'round the market.
​

🚗 Tesla gets China lift​
Tesla (TSLA) China-made EV sales increased 35% in Jan – Feb while BYD deliveries fell 36%, giving traders fresh demand data out of China [Link]

​
​🧾 Dick’s pays merger costs​
Dick’s Sporting Goods (DKS) beat Q4 estimates but missed profit guidance as Foot Locker cleanup costs keep hitting earnings [Link]

​
​🧠 Nvidia’s next chip moment​
Nvidia (NVDA) heads into GTC with new details expected on its $20B Groq deal and its next AI chip push [Link]

​
​✈️ Airlines pass on fuel pain​
United (UAL), Delta (DAL), American (AAL), and Southwest (LUV) face higher costs after jet fuel jumped over 60%, and CEOs update outlooks Tuesday at JPM’s Industrials conference [Link]

​
​🚙 Rivian’s R2 starts at $58K​
Rivian (RIVN) launches its R2 this spring with a ~$58K model while the $45K version waits until late 2027 [Link]

​
​💰 Nebius pops on Nvidia check​
Nebius Group (NBIS) rose 10% after Nvidia (NVDA) announced a $2B investment tied to AI cloud infrastructure buildout [Link]

🤳🏾 Let me check my palm pilot
​Earnings events on deck this coming week.

Market Outlook
​A look at how the market does historically over the next week.

Data provided by Swingset.

Trend of the Week

Philip Morris (PM) has a trend of going up over the next week.

​
It's gone up 11 out of the last 15 years moving an average of 2.68% and projected to repeat this move Mar 13th - 20th.

💫 TMYK - Answer

When bond ______ rise, stocks often struggle because “safe” returns start looking better.

c.) yields
​

Higher yields can pull money toward bonds and also raise borrowing costs for companies, which can weigh on stock prices.

To wealth in every sense of the word, Tela Holcomb ​​​​

​

Did someone forward you this email? Sign up for MRKTcap here​

Sent to: Reader

​
Copyright Simply Put
6935 Aliante Pkwy Ste 104-236, North Las Vegas, NV 89084
​

This newsletter is by no means a solicitation to buy or sell any of the above-mentioned securities. It is for educational and entertainment purposes only. Any views expressed here do not necessarily reflect the views of any affiliate. Expressions of opinion are as of this date, are solely that of the writer and are subject to change without notice. All investments involve risk including the loss of principal and past performance does not guarantee future results. Always do your own research and due diligence. This newsletter may contain affiliate links and we may receive commissions, at no cost to you, for purchases made through links in this email. The MRKTcap team often invests in the same stocks that we cover.

*Referral Program Terms and Conditions​

​
Need to change your name or the email I can reach you at?
​Update your preferences​

​
Not feeling the weekly breakdown?
​Leave MRKTcap but stay on our list​

​
Don't want to hear from me again? Like eva, eva??
​Unsubscribe from everything​